Acute myeloid leukemia suppression by palbociclib and ponatinib in patient-derived xenograft

BUŠA, Daniel, Martin ČULEN, Ivana JEŽÍŠKOVÁ, Adam FOLTA and Jiří MAYER. Acute myeloid leukemia suppression by palbociclib and ponatinib in patient-derived xenograft. In EHA 2022 in HemaSphere 2022; 6(S3): 574-575. 2022.

Basic information

• Original name: Acute myeloid leukemia suppression by palbociclib and ponatinib in patient-derived xenograft
• Authors: BUŠA, Daniel, Martin ČULEN, Ivana JEŽÍŠKOVÁ, Adam FOLTA and Jiří MAYER.
• Edition: EHA 2022 in HemaSphere 2022; 6(S3): 574-575, 2022.

Other information

• Type of outcome: Conference abstract
• Confidentiality degree: is not subject to a state or trade secret
• Organization unit: Faculty of Medicine

Links

• MUNI/A/1330/2021, interní kód MU: Name: Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IX (Acronym: VýDiTeHeMa IX)

Investor: Masaryk University